Starbucks and Bolthouse Farms "announced entry into a definitive agreement for Bolthouse Farms to acquire the brand and business of Evolution Fresh. The partners that support the business will also transition to Bolthouse Farms upon close of the transaction. The transaction, which is for an undisclosed amount, is expected to close later this year."

Allegiance Bancshares (ABTX) and CBTX (CBTX) announced that their respective shareholders had approved the agreement for the merger of equals of Allegiance and CBTX. These approvals complete another step in the process to establish Stellar Bank, a premier local bank with the scale and capabilities to provide extraordinary service to a broad range of business and consumer customers throughout the Houston region and beyond. The companies expect to close the merger after receipt of regulatory approvals and the satisfaction of other customary closing conditions.

In a regulatory filing, Cadence Design disclosed that Executive Chair Lip-Bu Tan sold 40K shares of common stock on May 20th in a total transaction size of $5.75M.

In a regulatory filing, Appian disclosed that one of its top institutional holders, Abdiel Capital, bought 163.4K shares of common stock on May 20th in a total transaction size of $7.18M. Shares of AdaptHealth are up 3.9% at $43.19 afterhours.

According to a post on the FDA's website, Janssen's treatment of primary failure of platelet recovery or secondary failure of platelet recovery in patients who have undergone allogeneic hematopoietic stem cell transplant, received FDA orphan designation. Reference Link

In a 13D/A filing, Wendy's shareholder Trian stated: "In the course of their discussions with the Board and management of the Company regarding the foregoing matters, on May 24, 2022, the Filing Persons advised the Board that they intend to explore and evaluate the possibility of the Filing Persons' (or one or more of their affiliates') participating, alone or with third parties, in a potential transaction with respect to the Company to enhance shareholder value. Such a potential transaction could include an acquisition, business combination (such as a merger, consolidation, tender offer or similar transaction) or other transaction that would result in the acquisition of control of the Company by the Filing Persons and/or their affiliates, and could include one or more of the types of transactions described in sub-paragraphs (a) through (j) of Item 4 of Schedule 13D. The Filing Persons (or their affiliates) expect to engage in communications and discussions with the Company, members of the Board and management of the Company, other current or prospective shareholders of the Company, potential co-investors and financing sources (including current or potential investors in funds managed by Trian Management), investment and financing professionals, industry analysts and other knowledgeable industry or market observers and participants, and other interested parties regarding a potential transaction and/or the matters set forth in this Item 4, and may exchange information with such persons pursuant to appropriate confidentiality or similar agreements. The Filing Persons (and/or their affiliates) may submit to the Company proposals relating to a potential transaction and may take such other steps as the Filing Persons may deem appropriate from time to time in connection with such a transaction. There can be no assurance that any such proposals will be submitted by the Filing Persons or that any transaction will result from any such discussions or proposals, and the Filing Persons are under no obligation to propose or consummate any transaction. The Filing Persons have retained, and may in the future retain, financial, legal and/or other advisors or consultants to assist them in evaluating their investment in the Company."

Raytheon was awarded a $217.12M fixed-price-incentive, firm-fixed-price contract. This contract procures 154 full-rate production Block V Tactical Tomahawk All Up Round Vertical Launch System missiles as follows: 70 for the Navy, 54 for the Marine Corps, and 30 for the Army. Work is expected to be completed in January 2025. FY22 weapons procurement funds in the amount of $98.69M; FY22 procurement of ammunition funds in the amount of $73.31M; FY22 research, development, test and evaluation funds in the amount of $42.3M and FY22 research, development, test and evaluation funds in the amount of $2.82M will be obligated at the time of award, none of which will expire at the end of the current fiscal year. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air Systems Command is the contracting activity.